Document Type : Research Paper
Authors
1 University of Anbar - College of science
2 University of Baghdad - College of science
Abstract
Staphylococcus aureus is a major cause of bacterial poisoning and spread widely in Iraq. In this study vancomycin resistant S. aureus (VRSA) were isolated from wounds, skin, and nose of human . The isolates were identified by using biochemical tests.Sixty one (72.6%) isolates were identified as S.aureus, followed by CoNS 23 (27.3%) from 250 sample collected. Antibiotic susceptibility was determined by disk diffusion ,the results of the susceptibility test indicated that 59 S. aureus isolates have different levels of resistance to antibiotics.In this study tow methods were used to identify resistant and intermediate resistance to vancomycin: which were Kirby-Bauer disk diffusion and automated system Vitek2 method. Results of Disk diffusion method indicated that (19.6%) isolates were resistant to vancomycin.The results of Vitek2 resistant test for 20 isolates indicated that 9(45%) isolates were resistant to vancomycin, with MIC value of (32 μg / ml); 3(15%) isolates showed intermediate resistant to vancomycin, with MIC value of (4 μg / ml),8(40%) isolates showed sensitive to vancomycin with MIC value of (≤0.5-2 μg / ml).Population analysis profile (PAP) method was uesd to detect Heteroresistant Vancomycin-Intermediate Staphylococcus aureus for the 10 isolates. The results showed that 9 (90%) isolates of S.aureus were resistant to vancomycin , while 1(10%) isolate was sensitive.
Keywords
Main Subjects
1. Jihad B., Elad G. , Leonard L. , Zmira S. , Hila S. , Nariman M. and Mical Paul.(2012). Healthcare-associated vs. hospital-acquired Staphylococcus aureus bacteremia . Inte. J. Infec. Diseases. 16 ; e457–e463.
2.Steven L., Louise S., Claudia V. and Gianfranco D. (2015). Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control. J. Medi. Microb. , 64, 323–334.
3.Biljana M. , Marina D., Jovan O. and Tatjana B.(2015). Staphylococcus aureus: Immunopathogenesis and Human Immunity. Acta facultatis medicae Naissensis; 32 (4) : 243-257.
4.Pesavento L., Casey A. and Elliot T. (2007).Staphylococci. Inter. J Antimicrob. Agents, 29, 23–32.
5.Jeremiah N., Neven B., Gentili M., Callebaut I., Maschalidi S., Stolzenberg MC, Goudin N., Frémond ML., Nitschke P., Molina TJ., Blanche S., Picard C., Rice GI., Crow YJ., Manel N., Fischer A., Bader B. and Rieux F.(2014). Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest. Dec;124(12):5516-20.
6. Schleifer ,K. and Bell, J. (2009). staphylococcus aureus .(pp:392-420) .In: Parte, A. C.; Whitman, W.B.; Vos, P. De, G. M.;Garrity, N. R.; Ludwig, W.; Rainey, F. A.;Schleifer, K. and Whitman ,W. B. (eds),Bergey's Manual Of Systematic Bacteriology. Biological Sciences Building University of Georgia Athens, GA –USA. Chapter tow.
7. CLSI. Clinical Laboratory Standards Institute. (2016). “Performance Standards for Antimicrobial Susceptibility Testing,” Twentieth Informational Supplement.
8.Hiramatsu, K. and Hanaki, H. (1997). Ino T, Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40: 135-6.
9.Brooks, G.; Carroll, K.; Butel, J. and Morse, S. (2007). Jawetz , Melnick and Adelbergs Medical Microbiology. 24th. ed. The McGraw-Hill Companies, Inc., New York. P.224-232.
10.Dubey, R. and Maheshwari, D.(2009).A textbook of Microbiology. 1 ed.S. Chand and Company LTD. New Delhi.
11.MacFaddin, J. (2000) . Biochemical Tests for Identification of Medical Bacteria. 3rd.ed. Lippinocott Williams &Wilkins, USA. 30:555-565.
12.Vos, P.; Garrity, G.; Jones, D.; Krieg, N.; Ludwig, W.; Rainey, F.; Schleifer, K. and Whitman, W. (2009). The Firmicutes In: Bergey`s Manual of Determinative Bacteriology. 2nd ed. Volume 3. Springer, New York.
13.Zebovitz, E.; Evans, J. and Niven , C. (1955). Tellurite-glycine agar: a selective plating medium for the quantitative detection of coagulase-positive staphylococci. J. Bacteriol. 70: 686-690.
14.Abd-Elateef, A. (2011). Comparative Study between Local Isolates of Methicillin Sensitive and Resistance of Staphylococcus epidermidis. M. Sc. thesis, college of science, university of Baghdad, Iraq.
15.Al-Hasani, H. (2011). Comparative study between methicillin-resistant coagulase positive and negative staphylococci on some virulence factors. Thesis, B.Sc. Biology and Microbiology, College of Science, Diyala University.
16.AL-azzawi, H. (2014). Detection of Vancomycin-Resistance among Methicillin-Resistant Staphylococcus aureus and their effect on Autolysis. M.Sc. thesis, college of science, university of Baghdad, Iraq.
17.Japoni, A.; Alborzi, A.; Rasouli, M. and Pourabbas, B. (2007) . Modified DNA extraction for rapid PCR detection of methicillin resistant Staphylococci. Iranian Biomed. J. 8: 61–65.
18.Ekrami , A. and Kalantar , E. (2007).Bacterial infections in burn patients at a burn hospital in Iran. Indian J. Med. Res. 126: 541–544.
19.Mehdinejad, M.; Frajzade, A. and Jolodar, A. (2008).Study of methicillin resistance in Staphylococcus aureus and species of coagulase negative staphylococci isolated from various clinical specimens . Pak. J. Med. Sci. 24: 115–117.
20.Neeta, D. and Mohiuddin, S. (2013). Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?. J Lab Physicians. 5(2): 109–112.
21.Kshetry, A.; Pant, N.; Bhandari, R. (2016). Minimum inhibitory concentration of vancomycin to methicillin resistant Staphylococcus aureus isolated from different clinical samples at a tertiary care hospital in Nepal. Antimicrob. Resist. & Infect. Control. 5(1, article 27).
22.Mir B. (2013). Srikanth Prevalence and antimicrobial susceptibility of methicillin resistant Staphylococcus aureus and coagulase-negative Staphylococci in a tertiary care hospital. Asian Journal of Pharmaceutical and Clinical Research. 6(3): 231–234.
23.Tiwari, H.; Das, A.; Sapkota, D.; Sivarajan, K.; Pahwa, V. (2009). Methicillin resistant Staphylococcus aureus: prevalence and antibiogram in a tertiary care hospital in western Nepal. J. Infect. Develop. Count.; 3(9):681–684.
24.Khanal, L. and Jha, B. (2010). Prevalence of methicillin resistant Staphylococcus aureus (MRSA) among skin infection cases at a hospital in Chitwan, Nepal. Nepal Med. Colleg. J.; 12(4):224–228.
25.Zeidan, I. (2005). Bacteriological and genetic study on Different clinical samples of Staphylococcus aureus resistant to vancomycin. Thesis. Baghdad university - college of science.100 p.
26.Abdulbari, S. and Adil, S. (2011). Isolation and identification of Staphylococcus from patient with intestinal and respiratory diseases in the province of Muthanna and examination of the resistant towered antibiotics. 1(4): 61-62.
27.Cennet , R.; Mehmet , P.; Yasemin , B.; Huseyin , G. and Nesrin , C.(2016). Evaluation of Antimicrobial Resistance in Staphylococcus aureus Isolates by Years. Int. P. on Infect. Dis. ID 9171395.
28.Wenjing, Z.; Wulin, S.; Xiaoling, M.; Wenjiao, C.; Xin ,Z.; Huaiwei, L. and Yuanyuan, D. (2012). Molecular characterization of rifampicin-resistant Staphylococcus aureus isolates in a Chinese teaching hospital from Anhui, China. BMC Microb. 12: 240.
29.Alka , H.; Vajihe , S.; Akbar , H.; Behrouz , N.; Vahide , V. and Ali , R. N.(2013). Methicillin resistant and susceptible Staphylococcus aureus: Appraising therapeutic approaches in the Northwest of Iran. Iran J. Microbiol.; 5(1): 56–62.
30.Campbell, E.; Korzheva, N.; Mustaev, A.; Murakami, K.; Nair, S.; Goldfarb, A. and Darst S. (2001).Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell. 104(6): 901-912.
31.Raghabendra , A. ; Narayan , D. ; Sanjeev , N. ; Mukesh , N. ; Roshan, B. ; Sabita , B.; Raina, C. and Binod , L.(2017). Detection of Methicillin Resistant Staphylococcus aureus and Determination of Minimum Inhibitory Concentration of Vancomycin for Staphylococcus aureus Isolated from Pus/Wound Swab Samples of the Patients Attending a Tertiary Care Hospital in Kathmandu, Nepal . Can. J. Infect. Dis. Med. Microbiol.: 2191532.
32.Kavitha, P.; Sunil, R. and Venkatakrishna, R. (2011). Inducible Clindamycin Resistance in Staphylococcus aureus Isolated from Clinical Samples. J Lab Physicians. 2011 Jan-Jun; 3(1): 25–27.
33.ALTameemi, A. (2010). Genetic Study of the Vancomycin-Resistant Staphylococcus spp. Thesis, Diyala University- College of Education for Pure Science.125 p.
34.Theaker, C.; Ormond-Walshe, S. and Azadian, B. (2001). MRSA in the critically ill. J. Hosp. Infect., 48" 98-102.
35.Al-Hossainy, D. (2007).Isolating and diagnosis Staphylococcus aureus bacteria from patients infection of urinary tract infection in Al-Diwanyia city. Al-Qadisiyah J. Scie. Veterinar. Med. 6(1): 52-57.
36.Rushdy, A.; Salama, M. and Othman, A. (2007). Detection of Methicillin/Oxacillin Resistant Staphylococcus aureus Isolated from Some Clinical hospitals in Cairo Using Meca/ Nuc Genes and Antibiotic Susceptibility profile. Internat. J. Agricultu. and Biol.; 9(6): 800-806.
37.Mohammed, S. (2011).Use of Cefoxitin as indicator for detection of Methicillin Resistant Staphylococcus aureus. Baghdad Sci. J. 8 (4): 947-955.
38.Al-Geobory, H. (2011). Comparative study between Methicillin resistant Staphylococcus aureus (MRSA) and Methicillin sensitive Staphylococcus aureus (MSSA), and detect the antimicrobial effects of some plant extracts on them. M.Sc. Thesis, College of Science, Baghdad University.
39.Angela, B.; Catia, A.; Claudia, F.; Ivano de, F.; Maysa M. (2015). Methicillin and vancomycin-resistant Staphylococcus aureus in health care workers and medical dev. J .Bras. Patol. Med. Lab. 51(3): 143-152.
40.Stevens, D. (2007). Genetics of MRSA: The United States and Worldwide. P. 31-41. In, J. A. Weigelt (ed.). MRSA. Informa Healthcare, New York.
41.Kolář, M.; Bardoň , J. ; Hanulík , V.; Sauer , P.; Babák, V. and Schlegelová , J. ( 2010) . Resistance to Methicillin in Coagulase-negative Staphylococci and Its Detection. Acta Vet. Brno.79: 261-267.
42.Khan, S.; Nawaz, M.; Khan, A.; Hopper, S.; Jones, R. and Cerniglia, C. (2005). Molecular characterization of multidrugresistant Enterococcus spp. from poultry and dairy farms: detection of virulence and vancomycin resistance gene markers by PCR. Mol.Cell Probes 19:27–34.
43.Sanches,S. ; Mato, R.; de Lencastre, H and Tomasz, A.( 2000). Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998. Microb. Drug Resist. 6: 199–211.
44.Tenover,F., Lancaster,M., Hill, B., Steward ,C., Stocker ,S., Hancock ,G., O'Hara,C., McAllister, S., Clark ,N., Hiramatsu, K. (1998). Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol. ;36 (4):1020–1027.
45.Michael, J.; Celine, V.; Helio, S.; Paul, R.; Hossein, S.; Lawrence, E.; Audrey, W. ; Ronald, N. and Jonesc, G. (2013). Evaluation of Vancomycin Susceptibility Testing for Methicillin-Resistant Staphylococcus aureus: Comparison of Etest and Three Automated Testing Methods. J. Clin. Microbiol.; 51(7): 2077–2081.
46.Bloomgren, B and Laible, B. (2013). Etest versus vitek 2 vancomycin minimum inhibitory concentration testing methods for methicillin-resistant staphylococcus aureus: an antimicrobial stewardship initiative to evaluate the degree of discordance among methods at a rural tertiary hospital. J. Pharm. Pract. 26(4):415-419.
47.Sharma, P. and Vishwanath, G. (2012). Study of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus isolated from clinical samples. Ann. Trop. Med. Pub. Health. 5:178-80.
48.Leonard, S.; Rossi , K.; Newton, K. and Rybak,M.(2009). Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides. Antimicrob Chemother. 63(3):489-92.
49.Horne, K.; Howden, B. ; Grabsch, E. ; Graham,M. ; Ward, P. ; Xie, S.; Mayall B.; Johnson, P. and Grayson, M.(2009).Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. Antimicrob Agents Chemother. 53(8): 3447-52.
)
